Heterologous DNA-VLP Prime-Boost Strategy Against H5N1 Virus
Author Information
Author(s): Ding Heng, Tsai Cheguo, GutiƩrrez Ramona Alikiiteaga, Zhou Fan, Buchy Philippe, Deubel Vincent, Zhou Paul
Primary Institution: Institut Pasteur of Shanghai, Chinese Academy of Sciences
Hypothesis
The combination of DNA plasmid and virus-like particle vaccines will provide better immune protection against HPAI H5N1 viruses than using either vaccine alone.
Conclusion
The heterologous DNA-VLP prime-boost strategy elicits superior neutralizing antibody responses and protection against HPAI H5N1 viruses in mice.
Supporting Evidence
- DNA-VLP elicited the highest neutralizing antibody titers among the three prime-boost strategies.
- Only DNA-VLP and DNA-DNA protected mice from infection as shown by no weight loss and no lung pathology.
- After a high lethal dose challenge, 3 of 6 mice in the DNA-VLP group survived.
Takeaway
Researchers found that a new vaccine method using two different types of vaccines worked better to protect mice from a dangerous bird flu virus.
Methodology
Mice were vaccinated with different prime-boost strategies and then challenged with H5N1 viruses to assess immune response and protection.
Potential Biases
Potential bias in animal model selection and the specific strains of H5N1 used.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female BALB/c mice, aged 6 to 8 weeks.
Statistical Information
P-Value
0.028
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website